Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Allogeneic adipose-derived mesenchymal stromal cell injection for knee osteoarthritis
IRCT20080728001031N23Phase 2Completed
- Sponsor
- Royan Institute
- Start
- Mar 2017
- Modality
- Stem Cell Therapies → Cell Therapies
- Countries
- 1
01
Overview
Phase 2 trial of allogeneic adipose-derived mesenchymal stromal cells in knee osteoarthritis (OA) (3 arms), sponsored by Royan Institute. Primary endpoints: Pain, Physical activity / physical function and 2 more. Started Mar 2017; status: completed.
02
Drugs
allogeneic adipose-derived mesenchymal stromal cells
03
Conditions
knee osteoarthritis (OA)
Beyond the preview
Go deeper on IRCT20080728001031N23.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20080728001031N23.